These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10609935)

  • 41. Diversification of both KIR and NKG2 natural killer cell receptor genes in macaques - implications for highly complex MHC-dependent regulation of natural killer cells.
    Walter L; Petersen B
    Immunology; 2017 Feb; 150(2):139-145. PubMed ID: 27565739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Killer immunoglobulin-like receptor gene distribution in Guangdong Han population].
    Yin XL; Guo KY; Ma HJ; Shang ZC; Xiao LL; Ye X; Zhao Y
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1416-8. PubMed ID: 15604074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors.
    Rajalingam R; Parham P; Abi-Rached L
    J Immunol; 2004 Jan; 172(1):356-69. PubMed ID: 14688344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
    Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
    Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P
    J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KIR and KIR ligand polymorphism: a new area for clinical applications?
    Falco M; Moretta L; Moretta A; Bottino C
    Tissue Antigens; 2013 Dec; 82(6):363-73. PubMed ID: 24498992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation.
    Velardi A; Ruggeri L; Capanni M; Mancusi A; Perruccio K; Aversa F; Martelli MF
    Hematol J; 2004; 5 Suppl 3():S87-90. PubMed ID: 15190285
    [No Abstract]   [Full Text] [Related]  

  • 48. Identification of bidirectional promoters in the human KIR genes.
    Davies GE; Locke SM; Wright PW; Li H; Hanson RJ; Miller JS; Anderson SK
    Genes Immun; 2007 Apr; 8(3):245-53. PubMed ID: 17315044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic control of human NK cell repertoire.
    Shilling HG; Young N; Guethlein LA; Cheng NW; Gardiner CM; Tyan D; Parham P
    J Immunol; 2002 Jul; 169(1):239-47. PubMed ID: 12077250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.
    Gagne K; Busson M; Balere-Appert ML; Absi L; Jollet I; Bignon JD; Bois M; Dormoy A; Dubois V; Gebuhrer L; Loiseau P; Masson D; Moine A; Perrier P; Reviron D; Charron D; Raffoux C;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():118-22. PubMed ID: 17445183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of killer cell immunoglobulin-like receptors with scleroderma.
    Momot T; Koch S; Hunzelmann N; Krieg T; Ulbricht K; Schmidt RE; Witte T
    Arthritis Rheum; 2004 May; 50(5):1561-5. PubMed ID: 15146426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
    Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
    J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs.
    Storset AK; Slettedal IO; Williams JL; Law A; Dissen E
    Eur J Immunol; 2003 Apr; 33(4):980-90. PubMed ID: 12672064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes.
    Scquizzato E; Teramo A; Miorin M; Facco M; Piazza F; Noventa F; Trentin L; Agostini C; Zambello R; Semenzato G
    Leukemia; 2007 May; 21(5):1060-9. PubMed ID: 17361229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific amplification of cDNA ends (SPACE): a new tool for the analysis of rare transcripts and its application for the promoter analysis of killer cell receptor genes.
    Radeloff B; Nagler L; Zirra M; Ziegler A; Volz A
    DNA Seq; 2005 Feb; 16(1):44-52. PubMed ID: 16040346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modelling KIR-HLA genotype disparities in type 1 diabetes.
    van der Slik AR; Alizadeh BZ; Koeleman BP; Roep BO; Giphart MJ
    Tissue Antigens; 2007 Apr; 69 Suppl 1():101-5. PubMed ID: 17445178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression.
    Yawata M; Yawata N; McQueen KL; Cheng NW; Guethlein LA; Rajalingam R; Shilling HG; Parham P
    Immunogenetics; 2002 Nov; 54(8):543-50. PubMed ID: 12439616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunology. The footprint of a killer.
    Kärre K; Schneider G
    Nature; 2000 Jun; 405(6786):527-8. PubMed ID: 10850700
    [No Abstract]   [Full Text] [Related]  

  • 59. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.
    van der Slik AR; Koeleman BP; Verduijn W; Bruining GJ; Roep BO; Giphart MJ
    Diabetes; 2003 Oct; 52(10):2639-42. PubMed ID: 14514651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. beta 2-Microglobulin in transplantation.
    Zeff RA
    Transplantation; 1995 Aug; 60(3):215-20. PubMed ID: 7645032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.